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Abstract
Age-related Macular Degeneration (AMD) is an acquired retina disease that can
potentially cause significant central visual impairment. Optical coherence tomogra-
phy (OCT) applied to the study of retinal pathologies has revolutionized the
understanding and management of AMD, especially with the technology of full-
depth imaging (FDI) Spectral Domain (SD) OCT. With the increasing amount of
data from several important studies using SD-OCT and OCT-angiography (OCT-A)
we can now better classify and more accurately decode AMD. The purpose of this
chapter is to describe the most important AMD biomarkers recently discovered
using SD OCT. Understanding AMD phenotype is very important to define prog-
nosis and individualized forms of treatment and follow up. Biomarkers on OCT
have been crucial for a better understanding of AMD.
Keywords: AMD, phenotyping, OCT
1. Introduction
Age-related Macular Degeneration (AMD) is an acquired retina disease that can
potentially cause significant central visual impairment. Advanced forms of the
disease may present as areas of retinal pigment epithelium (RPE) loss,
subretinal/sub-RPE hemorrhage or serous fluid, as well as subretinal fibrosis.
Severely affected areas may have no visual function, since loss of RPE is associated
with photoreceptor collapse.
When OCT (Optical Coherence Tomography) was not available yet, several
studies proposed classifications using a wide variety of parameters for AMD grading
systems [1–3]. In order to facilitate data comparison among those studies and
develop a core grading system using color stereoscopic fundus photography, the
International Age-Related Maculopathy Epidemiological Study Group compiled the
results of a series of meetings among groups involved in the epidemiological analy-
sis of Age-Related Maculopathy (ARM) [4].
Also The Macular Photocoagulation Study Group contributed significantly to
AMD grading, to the understanding of natural history of subfoveal neovascu-
larization as well as to the effectiveness of laser photocoagulation on juxtafoveal
neovascularizations [5].
OCT applied to the study of retinal pathologies has revolutionized the under-
standing and management of AMD, especially with the technology of full-depth
imaging (FDI) Spectral Domain (SD) OCT. With the increasing amount of data
from several important studies using SD-OCT and OCT-angiography (OCT-A) we
can now better classify and more accurately decode AMD.
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The purpose of this chapter is to describe the most important AMD biomarkers
recently discovered using SD OCT.
2. Cuticular Drusen
Cuticular drusen were first described by Gass in 1977 and consist of a subtype of
drusen characterized by being much more numerous than small hard drusen [6].
They frequently coalesce revealing a diffuse appearance. On fluorescein angiogra-
phy (FA), they are seen as a starry-sky fluorescence pattern that is most evident
during the early arteriovenous phase. Some authors suggested that cuticular drusen
are often initially visible in the peripheral or midperipheral retina, where the rod-
to-cone ratio is the highest [7, 8]. On fundus autofluorescence (FAF), the lesions
have a central hypoautofluorescent area with a rim of hyperautofluorescence. The
central hypoautofluorescent area corresponds to the area of central
hyperfluorescence on FA.
Based on studies with light microscopy and transmission electron microscopy,
the location of cuticular drusen was determined to be at the same of hard small
drusen and soft drusen: between the inner collagenous layer of the Bruch’s mem-
brane and the basal lamina of the RPE [9, 10]. Cuticular drusen are small with steep
sides and contain a dense hyalinized component that is identical to hard drusen.
This contrasts with soft drusen, which are larger and have sloping sides.
On B-Scan SD-OCT, cuticular drusen are located beneath the RPE and imprint
the area below with a pattern of hyperreflectivity alternated with hyporreflectivity,
providing an aspect similar to a barcode sign. This aspect is due to the thinning of
the RPE at the apex of the drusen and thickening at the base of the drusen. On SD-
OCT, the height of drusen did not correlate with the area of hyperfluorescence on
FA or hypoautofluorescence on FAF (Figure 1).
Figure 1.
Cuticular drusen. Type 1 (green arrowhead): Shallow elevations of the RPE and basal laminar band. Type 2
(red arrowhead): Triangular shape resulting in a saw-tooth appearance and hyporreflective internal contents.
Type 3 (yellow arrowhead): Mound-shaped elevations of the RPE and basal laminar band with hyporreflective
internal contents.
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The morphological features of cuticular drusen seen on SD OCT B-scans can be
categorized into 3 patterns:
1.Type 1 (33%): characterized by shallow elevations of the RPE
2.Type 2 (49%) with a triangular shape, resulting in a saw-tooth appearance,
and hyporreflective internal contents
3.Type 3 pattern (18%) characterized by broad, mound-shaped elevations of the
RPE with hyporreflective internal contents [11].
Near infra-red (NIR) images showed variable reflectivity patterns of cuticular
drusen: hyporreflective centers with a surrounding hyperreflective margin in
53.9%, diffuse hyperreflectivity in 15.2%, heterogeneous reflectivity in 3.9%, and a
combination of these patterns in 27.0%. These variations of aspects demonstrate
that the accurate detection of the cuticular drusen phenotype requires the integra-
tion of data from more than one imaging method [11].
In a very extensive multimodal analysis, cuticular drusen were shown to be
involved in the formation of: RPE clumping, large drusen, vitelliform lesions and
subretinal neovascular membranes [11]. In the entire cohort of this study, new
pigmentary RPE abnormalities were identified in 47.5% of eyes, large drusen in
45.4%, drusen resorption in 58.3% and drusen coalescence in 70.8%.
Acquired vitelliform lesions (AVL) involving the central macula were seen in
24.2% of the eyes in the study. However, visual acuity in eyes with AVLs was not
significantly different from that in eyes without AVLs [11].
Geographic atrophy (GA) was identified in the macula of 25% of the eyes. The
frequency of atrophy in patients older than 60 years was significantly greater than
in those that were 60 years-old or younger (42.9% vs. 9.4%; p < 0.001). Visual
acuity (VA) in eyes with atrophy was significantly worse than in those without
atrophy (0.32 vs. 0.14 logMAR; p < 0.001) [11].
Twelve percent of the cases were complicated by choroidal neovascularization.
The frequency of neovascularization in patients older than 60 years was signifi-
cantly higher than in those that were 60 years-old or younger (19.6% vs. 6.2%; p
< 0.014). The vast majority of cases (76.7%) were of type 1 neovascularization,
while 9 cases were a mixture of type 1 and 2 lesions. There were no cases of type 3
macular neovascularization [11–13].
3. Reticular Drusen
Reticular pseudodrusen are multiple yellowish-white lesions arranged in a retic-
ular network pattern. A distinction between conventional drusen and pseudodrusen
was first made in 1990 by Mimoun et al. [14]. More recently the knowledge on
pseudodrusen, more accurately called subretinal drusenoid deposits (SDDs), has
expanded.
Reticular pseudodrusen have an increased visibility in blue light. On FAF imag-
ing, reticular drusen are shown as numerous spots of reduced autofluorescence,
with brighter lines in-between. SDDs frequently spares the fovea and usually are
distributed at the superior macula, which has the highest rod-photoreceptor density
[15]. Such topographic characteristic is probably related to a rod-photoreceptor
association [16–18].
The fluorescein angiographic findings of subretinal drusenoid deposits are
subtle, ranging from no demonstrable change to minimal hypofluorescence.
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On NIR photography, reticular drusen are hyporreflective lesions, most of them
with a lighter center, on a hyperreflective background. The area superior to the
fovea, which has the highest rod-photoreceptor density, is the most commonly
involved. The fovea, however, is typically spared [15].
The reticular pattern may not be needed for diagnosis, but most studies have
required at least five reticular pseudodrusen lesions and multiple imaging modali-
ties for confirmation of the diagnosis.
Histologic evaluation of these deposits revealed aggregation of material in the
subretinal space between photoreceptors and the RPE. SDDs contain some proteins
that are common to soft drusen but differ in lipid composition. There is a decrease
in the number of photoreceptor nuclei above the deposits. These deposits are
interconnected, forming a branching pattern [19].
SDDs contain some proteins that are common to soft drusen but differ in lipid
composition.
On OCT scans, these lesions are shown as collections of granular hyperreflective
deposits located between the RPE layer and the ellipsoid zone (Figure 2). These
deposits are more commonly seen in older eyes with thinner choroids. Currently, it
was shown that retinal thinning in early AMD with reticular pseudodrusen was
accompanied by choroidal and retinal vascular loss, which suggests that eyes with
reticular pseudodrusen may have limited compliance with changes in ocular perfu-
sion pressure at the level of choroidal and retinal vasculature [20].
OCT has been used to classify SDD into three subtypes [21]:
1.Type 1: characterized by the presence of hyperreflective material between the
RPE and the Inner/outer segment junction or ellipsoid zone (EZ). There is no
elevation or breach of the EZ
2.Type 2: characterized by hyperreflective material that accumulates and forms a
mound over the RPE, with distortion of overlying EZ
3.Type 3 characterized by hyperreflective material that has a conical
configuration which perforates the EZ and reaches the outer retina.
Figure 2.
Reticular drusen. The pink arrowhead indicates a stage 1 lesion where diffuse hyperreflective material between the
RPE and ellipsoid layer without elevation of the ellipsoid layer. The red arrowhead indicates a stage 2 lesion with
increased accumulation of hyperreflective material and distortion of the ellipsoid layer. The yellow arrowhead
indicates a stage 3 lesion that has a characteristic conical shape and has punctured through the ellipsoid layer.
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Many studies reported that SDDs are strong independent risk factors for late
AMD. GA and type 3 neovascularization are particularly associated with SDD.
Outer retinal atrophy develops in eyes with regression of SDD, a newly recognized
form of late AMD [19, 22].
4. Calcified soft Drusen
This type of drusen originates from classical drusen that had their colloidal
content mineralized along time. While classical drusen have a hyperreflective con-
tent due to the presence of colloid, calcified drusen have hyporreflective nodules
that correspond to hydroxyapathite crystals [23].
Calcified drusen have a glistening appearance due to calcium-containing spher-
ules and a depigmentation area around them. They present with reduced
autofluorescence. On OCT, they appear as hyperreflective dots on a hyporreflective
base, and they can cause shadowing of deeper structures (Figure 3). Refractile
deposits within drusen may indicate a higher rate of GA development.
There are three calcified structures associated with advanced AMD: 1) small
hyperreflective dots within drusen; [2] heterogeneous internal reflectivity within
drusen (HIRD) and 3) hyperreflective lines near the Bruch’s membrane. The compo-
sition of HIRD and the reason of its hyporreflectivity was not determined yet [24].
5. Subclinical Neovascular membranes
Subclinical neovascular membranes are membranes that are not exuding.
Therefore, this is an important biomarker either for an exudative form or for the
atrophic form of the disease.
Analyzing the NIR, B Scans and OCT-A, a neovascular complex can be observed
without exudation and it is providing an elevated but shallow contour of the
pigmented epithelium (Figure 4). The initial nomenclature of this type of mem-
brane was quiescent neovascular membrane but more recently terminology for this
finding is Shallow Irregular RPE Elevation (SIRE) [25, 26].
Figure 3.
Calcified small drusen (white arrowheads). In this OCT-B scan, it is possible to identify a hyperreflective sheath
with a hyporreflective content. There may be hyperreflective dots inside the lesions.
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The baseline prevalence of this type of neovascularization in patients with AMD
was around 13 to 14%. Exudative shift at 12 months had a prevalence of 6.8%
among patients without Non-Exudative Macular Neovascularization (NE-MNV)
and of 21.1% among patients with NE-MNV. Exudative shift at 24 months had a
prevalence of 6.3% among patients without NE-MNV and of 34.5% among patients
with NE-MNV. Therefore, it is recommendable a very close follow-up of the
patients identified with SIRE [25, 26].
6. Hyperreflective foci
A concept that came to light with SD-OCTs, that we did not have previously
with angiography or retinography, is intraretinal hyperreflective foci (HRF). HRF
are well-circumscribed, discrete lesions with an equal or superior reflectivity com-
pared to the RPE band on OCT (Figure 5). They are usually associated with
hyperpigmentation on color fundus photography. There is an important specific
spatial correlation of HRF with the apex of drusen [27] and/or SDD [28]. Addition-
ally, there is an association between HRF overlying drusen and increased risk of
atrophy at that location. HRF in eyes with intermediate AMD could be the result of
migration of activated RPE cells into the inner retinal layers, as proposed by in vivo
OCT study [29].
Figure 4.
SIRE. Superiorly, en face OCT-A slabs show subretinal neovascular complexes. Inferiorly, the OCT-B scan
demonstrates a SIRE with the presence of heterogeneous material beneath the RPE. Additionally, it is possible to
note the absence of intraretinal or subretinal fluid.
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Its development is triggered by a process of gliosis and phagocytosis of the
Muller cells, followed by accumulation of decomposed cells in hyperreflective
deposits, such as the mechanism observed in MacTel. The debris can be located at
the external limiting membrane, external nuclear layer and the plexiform layer.
They are biomarkers of poor prognosis, because they reveal that Muller Cells are
losing their structure and will collapse [30].
Among patients classified as having intermediate AMD, the choriocapillaris flow
deficit is apparently worse in eyes with HRF and is commonly located directly
below HRF [31]. The amount of HRF was correlated with EZ normalized reflectivity
and drusen volume (DV), that are well-defined markers of photoreceptor damage
and AMD progression, respectively. Nassisi et al. [32] evaluated the correlation
between HRF quantity and progression to advanced AMD after 1 year. He con-
cluded that the area of HRF measured by en face OCT in eyes with intermediate
AMD was highly correlated with development of atrophy [33, 34].
7. Acquired Vitelliform lesion
AVLs are deposits of melanosomes, melanolipofuscin, lipofuscin and outer seg-
ment debris located between the RPE and the photoreceptor layer (Figure 6). Their
pathophysiology may be related to paraneoplastic, toxic, degenerative and
vitreoretinal interface disorders of the macula.
AVL were correlated with SDD and cuticular drusen in the past and can occur in
conjunction with large drusen. The same dysfunctional processes that lead to drusen
formation, or parallel processes, could be related to AVL formation [35].
On fundus exam and SD-OCT, AVLs manifests as yellowish deposits between
the EZ or external limiting membrane (ELM) and RPE. On FAF, they appear as
areas of hyperautofluorescence that corresponded to the sites where vitelliform
material was seen on SD-OCT and fundus exam. In some cases with
pseudohypopyon, on FAF it is possible to identify a hypoautofluorescent top
portion and a hyperautofluorescent inferior portion. On FA, there is early
Figure 5.
Hyperreflective foci are observed in the inner (pink arrowhead) and outer retina (orange arrowhead).
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hypofluorescence with a halo of hyperfluorescence. A progressive late staining of
the lesion was noted during the exam. On red-free imaging studies, AVLs manifest
with a slight hyperchromia of the material [36].
The lifecycle of an AVL is characterized by a phase of growth followed resorp-
tion and, over time, it can lead to complications as foveal atrophy and choroidal
neovascularization (type 1 in 8% of cases). These complications are frequent and
can impair central vision. There is a decrease in visual acuity from 0,3 to 0,5
logMAR (2 to 3 lines on log scale) in 7 years. Development of neovascular com-
plexes occurs during the collapse phase of the AVL life cycle, after the AVL peak
volume was reached. Type 1 choroidal neovascularization occurs in nearly 10% of
cases. The risk of neovascularization and the decline in best corrected visual acuity
(BCVA) are both significantly greater among eyes with AMD. Foveal atrophy was
the characteristic most significantly associated with final BCVA and with change in
BCVA from baseline. The development of neovascularization was not predictive of
long-term visual outcomes [37].
8. Drusenoid PED
Adrusenoid pigment epithelial detachment (PED) is a large elevation of theRPE that
is formed from the coalescence of drusen and colloid material. It is a hallmark feature of
AMD and a known precursor of GA. It may be distinguished from hemorrhagic and
serous PEDs by its appearance on clinical exam and angiography (Figure 7). Drusenoid
PEDs have an accelerated growth rate of 0,022mm3/month. Additionally, its rate of
collapse is 10 times faster: 0,199mm3/month, similarly to the observed in AVL. The
onset of intraretinal hyperreflective foci and AVL usually precedes its collapse.
Features such as maximal height, volume and diameter of drusenoid PEDs were
inversely correlated with visual acuity and directly correlated with the rate of
collapse [38].
Figure 6.
Acquired Vitelliform lesion: OCT B-scan detects an accumulation of hyperreflective material between the
ellipsoid layer and the RPE. This material (white arrowhead) is located above soft drusen, with discrete
thinning of the overlying outer retinal layers.
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9. Macular neovascularization
In the exudative form of AMD, the local production of vascular endothelial
growth factor (VEGF) promotes the growth of choroidal neovascularization. These
lesions were initially classified in: classic, occult, and variations (predominantly
classic and minimally classic) based on their characteristics on FA.
Gass proposed [39] that the location of the neovascular membrane could be
important to predict response to treatment and after the advent of OCT, an
alternative classification was suggested:
9.1 Type 1
In this type the vessels are located in the sub-RPE space (Figure 8). It is the most
common type of neovascularization in AMD. On FA, these lesions are depicted as
occult or poorly defined CNV (choroidal neovascularization). Other FA terminolo-
gies are used to describe type 1 neovascular complex: vascularized RPE,
vascularized PED or stippled hyperfluorescence. On indocyanine green angiogra-
phy (ICG-A), this neovascular membrane appears as an area of low-intensity
hyperfluorescence, known as plaque. On SD-OCT, it is possible to determine its
location on a space bounded inferiorly by the hyperreflective remnants of Bruch
membrane and superiorly by the hyperreflective RPE band. A new finding of the
type 1 neovascularization was described by Spaide [40] recently. It was observed
that when the RPE becomes elevated due to sub-RPE exudation, the neovessels
adhere to the basal surface of the RPE. On Enhanced Depth Imaging (EDI) OCT,
this is described as a hyperreflective material (supposed to be the neovascu-
larization) lining the undersurface of the elevated RPE. This pattern may explain
the vulnerability of type 1 neovascularization to RPE tears. This subgroup also
includes polypoidal vasculopathy, which was recently renamed as aneurysmal type
1 neovascularization.
Figure 7.
Drusenoid PED. In this OCT-B scan, it is possible to note a lesion that has an internal homogenous and mild
hyperreflectivity. The lesion is delimited by the Bruch’s membrane at its base.
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9.2 Type 2
It consists of a neovascular membrane that has perforated the RPE/Bruch mem-
brane complex and is growing in the space between the neurosensory retina and the
RPE [40]. On FA, these new vessels are commonly described as being classic or
having a well-defined contour (Figure 9). Due to the attenuation of the choroidal
fluorescence by the interjacent RPE promoting the formation of a dark background,
the new vessels appear to fluoresce intensely. On the other hand, on ICG-A it may
be challenging to identify the neovascular complex due to the intense
hyperfluorescence of the background choroidal circulation. It is common to detect
type 2 neovascularization along with type 1 vessels in exudative AMD. It is also
possible that a type 2 neovascular complex regresses and turns into a type 1.
On OCT, it is possible to detect a disorganization of the overlying inner/outer
segment junction in conjunction with intraretinal cystic spaces. Additionally, this
exam identifies intraretinal rather than subretinal fluid.
9.3 Type 3
Type 3 neovascularization is the recent terminology for what once was known as
Retinal Angiomatous Proliferation (RAP) and consists of an intraretinal neovascu-
larization. Notable discussions happened regarding whether the origin of this
neovascular complex was from the retinal circulation (as Yanuzzi suggested) or
Figure 8.
Type 1 neovascularization, also known as aneurysmal type 1 subretinal neovascular membrane. Inferiorly,
OCT-B scan demonstrates PED with shallow subretinal fluid and intraretinal cystic degeneration. Superiorly,
OCT-A slabs detect a branch vascular network ending in an aneurysm formation (yellow circle) located
between the RPE and the Bruch’s membrane.
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Figure 9.
Type 2 neovascularization. En face OCT-A projection images of the neovascular complex with vessels both in
the outer retina and the choriocapillaris (pink circles). Inferiorly, an OCT-B scan demonstrates the neovascular
complex (arrowhead) located between the RPE and the neurosensory retina.
Figure 10.
Type 3 neovascularization. On the left, en face OCT-A slabs show the vascular lesion (pink circles) in the
superficial and deep segments of the retina. The OCT-B scan, on the left, demonstrates the presence of
intraretinal fluid, caused by the vascular lesion before treatment with anti-VEGF (arrowhead). On the right,
en face OCT-A slabs still show the vascular lesion (orange circle), although the OCT-B scan, on the right,
demonstrates resolution of fluid after the first injection of anti-VEGF (this type of neovascularization tends to
respond well to treatment with anti-VEGF).
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from the choroidal circulation (as suggested by Gass). Some studies support the
theory that the origin of this neovascular complex can be from either circulation
and may arise from both circulations at the same time as a Retinal-Choroidal
Anastomosis (RCA) (Figure 10).
On OCT, it is characterized by large amounts of intraretinal fluid as well as a thin
choroid. In this aspect it differs from types 1 and 2 neovascularization that have an
associated thickened choroid. Another differential aspect, is that type 3 neovascu-
larization leads more often to retinal atrophy due to damage to the external retina
caused by its intraretinal origin and the thinner choroid [39, 41].
10. Outer retina atrophy
Geographic Atrophy (GA) is a late-stage disease manifestation of non-
neovascular AMD that generally progresses to severe central vision loss. It has
traditionally been defined on color fundus photography as a sharply delineated
circular or oval area of hypopigmentation or depigmentation in which choroidal
vessels are visible. The size required for a lesion to be classified as GA varies with
different studies, ranging from 175 μm to 430 μm in diameter.
Autofluorescence of these areas indicate them as hypoautofluorescent lesions,
that may have a hyperautofluorescent rim, which is linked to acute suffering of the
RPE. Atrophic areas typically demonstrate a late well-defined hyperfluorescence.
On OCT, as drusen regress, the overlying retinal layers undergo characteristic
changes, while progressing to atrophy, that can be captured on OCT imaging. These
changes, referred to as nascent GA in previous reports, include subsidence of the
inner nuclear layer (INL) and outer plexiform layer (OPL), a hyporeflective wedge-
shaped band within the Henle fiber layer (HFL), often accompanied by RPE dis-
turbance, and increased signal hypertransmission into the choroid [42].
OCT-A shows significant impairment on the choriocapillaris flow in the zone
immediately surrounding GA lesions. OCT-A seems to be able to give us informa-
tion about the progression of atrophy, since the flow at the choriocapillary layer is
diminished in the perifoveal region if compared to the parafoveal regions [43].
Previous studies have identified characteristic fundus features that are associ-
ated with a high risk for progression to GA [44]. Features related to a greater chance
of developing GA are: large drusen volume, calcified drusen, intraretinal
hyperreflective foci and SDD.
Spaide was one of the first to describe that outer retina atrophy could result from
regression of SDD [45]. The outcomes of this study showed that, 43% of patients
would eventually develop choroidal neovascularization after a period of two years
and 43% would develop regression of SDD. Patients that had regression of SDD, had
a decrease in the photoreceptor length, decrease in choroidal thickness and loss of
ellipsoid band.
A score was proposed to better follow patients [28]. Among the scoring factors,
there are: hyporeflective drusen, hyperreflective intraretinal foci, subretinal
drusenoid deposits, and volume of large drusen. In order to generate the score, one
point was assigned to each feature present in the study eye. The fellow eye was
scored in a similar fashion. By adding the scores from both eyes, the total score (TS)
is calculated. Category I is defined as a TS of 0, 1 or 2. Category II is defined as a TS
of 3 or 4. Category III corresponds to a TS of 7 or 8. According to this score, in
category I there was 0% chance to develop retinal atrophy; in category II there was a
chance of 14,3%; in category III there was a chance of 47,5% and in category IV the
chance was of 73%. The results allowed to conclude that patients in category I could
be safely seen every 12 months, whereas patients in category II, III and IV could be
seen every 6, 4 and 3 months, respectively [28, 43].
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10.1 Classification of outer retina and RPE atrophy
GA usually is characterized by RPE atrophy and recently received the term RPE
and outer retina atrophy (RORA). When there is a photoreceptor loss without RPE
atrophy, the term proposed is outer retina atrophy (ORA). ORA also occurs in eyes
after regression of reticular pseudodrusen. SD-OCT is characterized by thinning of
the outer retina, including the ELM and the inner segment of the EZ band and
decreased choroidal thickness. ORA increases the risk for progression to RORA or
macular neovascularization [44].
Figure 11.
cRORA. The green arrow in the red-free image, on the left, shows the location where the OCT B-scan, on the
right, was taken. This scan demonstrates an area greater than 250μm in diameter with choroidal hyper-
transmission due to absence of the RPE layer and overlying outer retinal thinning and loss of photoreceptors.
Figure 12.
iRORA. OCT-B scan demonstrates choroidal heterogeneous hypertransmission (pink arrowhead), subsidence of
the INL and OPL (green arrowhead) as well as RPE attenuation and overlying photoreceptor disruption (red
arrowhead).
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Along several meetings, experts proposed a classification according to OCT
findings and four terms were described: cRORA, complete RPE and outer retina
atrophy; iRORA, incomplete RPE and outer retina atrophy; cORA, complete outer
retinal atrophy and iORA, incomplete outer retinal atrophy (Figures 11–14) [46].
iRORA is defined on OCT by the following criteria: (1) a region of signal
hypertransmission into the choroid, (2) a corresponding zone of attenuation or
disruption of the RPE, with or without persistence of basal laminar deposits, and (3)
Figure 13.
cORA. OCT-B scan demonstrates thinning of the outer retina with loss of visibility of the ELM, EZ, IZ
(interdigitation zone) (red arrowhead). It is possible to note regressing reticular pseudodrusen (yellow
arrowhead).
Figure 14.
iORA. OCT-B scan demonstrates thinning of the outer retina where intermittent areas of EZ and ELM can still
be identified (arrowhead). It is also possible to note an uninjured RPE layer.
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evidence of overlying photoreceptor degeneration (subsidence of the INL and OPL,
presence of a hyporreflective wedge in the henle fiber layer (HFL), thinning of the
outer nuclear layer (ONL), disruption of the external limiting membrane (ELM), or
disintegration of the EZ), and when these criteria do not meet the definition of
cRORA. A minimum size to determine that a lesion is iRORA was not proposed.
iRORA progresses into cRORA over a variable period, from months to years. If each
of the areas of RPE change and hypertransmission has a diameter of at least 250 μm
on the OCT B-scan, in addition to evidence of photoreceptor loss, then they qualify
as cRORA.
En face OCT allows to observe a hyperreflective contour that is the ELM descent.
On FAF, this border is hyperautofluorescent. Studies have confirmed histologically
that the descent ELM is an important biomarker for the development of a complete
atrophy of the RPE and outer retina. Increase of ELM reflectivity also was found as
possible biomarker for severe photoreceptor loss and gliosis [47–53].
Understanding AMD phenotype is very important to define prognosis and indi-
vidualized forms of treatment and follow up. Biomarkers on OCT have been crucial
for a better understanding of AMD.
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